| SS-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
10 |
|
12.68 |
ml/min/g |
0.99 |
3.13 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46680 |
461 |
| SS-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
10 |
|
6.52 |
ml/min/g |
0.72 |
2.27 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44745 |
461 |
| SS-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
57.46 |
% |
9.24 |
29.22 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46093 |
461 |
| SS-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
10 |
|
0.44 |
IU/g |
0.11 |
0.35 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47502 |
461 |
| SS-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
14.1 |
ml/min/g |
1.29 |
4.07 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46676 |
461 |
| SS-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
|
7.37 |
ml/min/g |
0.83 |
2.61 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
44741 |
461 |
| SS-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
15 |
post-ischemic value/pre-ischemic value x 100% |
50.28 |
% |
4.11 |
15.91 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46089 |
461 |
| SS-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
15 |
|
5.58 |
ml/min/g |
0.38 |
1.48 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46224 |
461 |
| SS-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
15 |
|
11.72 |
ml/min/g |
0.89 |
3.46 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46893 |
461 |
| SS-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
10 |
|
11.08 |
ml/min/g |
0.8 |
2.52 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46897 |
461 |
| SS-Chr 2BN/Mcwi |
arterial blood flow rate |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
9 |
|
6.65 |
ml/min/g |
0.58 |
1.74 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
46228 |
461 |
| SS-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
10 |
|
0.54 |
IU/g |
0.09 |
0.3 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47510 |
461 |
| SS-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
female |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
52.52 |
% |
3.24 |
10.24 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47100 |
461 |
| SS-Chr 2BN/Mcwi |
percent change in arterial blood flow rate |
controlled air oxygen content (12 %) (for 14 days) then controlled oxygen content Kreb's solution perfusate (for 0.5 hours) then perfusate suspended (for 0.4 hours) then controlled oxygen content Kreb's solution perfusate (for 0.7 hours) |
PhysGen Cardiac data |
arterial blood flow trait |
male |
49.0 days-63.0 days |
10 |
post-ischemic value/pre-ischemic value x 100% |
52.88 |
% |
4.88 |
15.43 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47104 |
461 |
| SS-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
female |
49.0 days-63.0 days |
13 |
|
0.29 |
IU/g |
0.05 |
0.17 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47365 |
461 |
| SS-Chr 2BN/Mcwi |
heart effluent lactate dehydrogenase activity level normalized to heart weight |
controlled oxygen content Kreb's solution perfusate (for 0.5 hours) |
PhysGen Cardiac data |
heart lactate dehydrogenase activity |
male |
49.0 days-63.0 days |
9 |
|
0.29 |
IU/g |
0.06 |
0.17 |
isolated perfused heart effluent collection |
|
|
Moms and pups used in studies were fed Teklad |
47372 |
461 |